Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Oct 31, 2025 → Jan 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ALKERMES PLC | 0 | 6,568 | 6,568 | 4.02% | $222.59K |
| SK BIOPHARMS. CO LTD | 0 | 1,801 | 1,801 | 2.65% | $146.95K |
| AVADEL PHARMACEU | 0 | 5,990 | 5,990 | 2.33% | $129.08K |
| BIOHAVEN LTD | 0 | 6,937 | 6,937 | 1.48% | $82.06K |
| PEIJIA MEDICAL LTD | 0 | 29,000 | 29,000 | 0.44% | $24.55K |
| PROTHENA CORP PLC COMMON STOCK USD.01 | 0 | 2,784 | 2,784 | 0.44% | $24.53K |
| ONCOLYS BIOPHARMA INC | 0 | 1,800 | 1,800 | 0.37% | $20.28K |
| BlackRock Cash Funds: Treasury, SL Agency Shares | 0 | 1,674 | 1,674 | 0.03% | $1.67K |
| JAPANESE YEN | 0 | 149,531 | 149,531 | 0.02% | $966 |
| SWISS FRANC | 0 | 743 | 743 | 0.02% | $962 |
| KOREAN WON | 0 | 1,337,671 | 1,337,671 | 0.02% | $929 |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0 | 753 | 753 | 0.02% | $893 |
| DANISH KRONER | 0 | 5,043 | 5,043 | 0.01% | $800 |
| FX Forward Contract: AUD/USD SETTLE 2026-03-18 | 0 | 729 | 729 | 0.01% | $508 |
| SWEDISH KRONE | 0 | 2,498 | 2,498 | 0.01% | $280 |
| HONG KONG DOLLAR | 0 | 1,359 | 1,359 | 0.00% | $174 |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ALKERMES PLC | 5,186 | 0 | -5,186 | 0.00% | -$159.21K |
| SK BIOPHARMACEUT | 1,884 | 0 | -1,884 | 0.00% | -$152.33K |
| AVADEL PHARMACEUTICALS PLC | 5,991 | 0 | -5,991 | 0.00% | -$113.17K |
| BIOHAVEN LTD | 6,159 | 0 | -6,159 | 0.00% | -$105.93K |
| PROTHENA CORP PLC | 2,898 | 0 | -2,898 | 0.00% | -$31.15K |
| PEIJIA MEDICAL | 31,000 | 0 | -31,000 | 0.00% | -$24.00K |
| Oncolys BioPharma Inc | 1,600 | 0 | -1,600 | 0.00% | -$7.77K |
| Shanghai HeartCare Medical Technology Corp Ltd | 1,100 | 0 | -1,100 | 0.00% | -$7.76K |
| NEURONETICS INC | 2,686 | 0 | -2,686 | 0.00% | -$7.12K |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| AXSOME THERAPEUTICS INC | 1,241 | 1,299 | 58 | 4.32% | $71.82K |
| ARGENX SE SPONSORED ADR | 207 | 215 | 8 | 3.26% | $11.28K |
| ACADIA PHARMACEUTICALS INC | 6,145 | 7,065 | 920 | 3.20% | $38.05K |
| XENON PHARMACEUTICALS INC | 3,960 | 4,307 | 347 | 3.19% | $10.63K |
| NEUROCRINE BIOSCIENCES INC | 1,077 | 1,247 | 170 | 3.06% | $15.43K |
| SUPERNUS PHARMACEUTICALS INC | 3,374 | 3,493 | 119 | 3.04% | -$17.79K |
| CENTESSA PHARMACEUTICALS LTD ADR | 5,727 | 6,159 | 432 | 2.73% | $8.72K |
| SAREPTA THERAPEUTICS INC | 6,253 | 6,336 | 83 | 2.33% | -$21.26K |
| DIANTHUS THERAPEUTICS INC | 1,565 | 2,253 | 688 | 2.17% | $65.54K |
| IDORSIA LTD | 10,322 | 10,661 | 339 | 0.91% | $5.59K |
| ANNEXON INC | 6,379 | 7,887 | 1,508 | 0.89% | $29.06K |
| RAPPORT THERAPEUTICS INC | 1,164 | 1,804 | 640 | 0.87% | $14.33K |
| SANBIO CO LTD | 3,500 | 3,700 | 200 | 0.80% | -$19.94K |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD | 12,000 | 12,500 | 500 | 0.71% | $3.04K |
| Bright Minds Biosciences Inc COM NEW | 472 | 500 | 28 | 0.70% | $13.03K |
| MICROPORT NEUROTECH LTD | 16,000 | 20,000 | 4,000 | 0.54% | $5.81K |
| CERIBELL INC | 1,354 | 1,418 | 64 | 0.53% | $13.79K |
| ANAVEX LIFE SCIENCES CORP | 5,535 | 5,784 | 249 | 0.49% | -$16.93K |
| BENITEC BIOPHARMA INC | 1,637 | 2,096 | 459 | 0.46% | -$1.25K |
| NEUROPACE INC | 1,571 | 1,634 | 63 | 0.45% | $9.11K |
| NEUROGENE INC | 804 | 856 | 52 | 0.27% | -$12.43K |
| TONIX PHARMACEUTICALS HOLDING CORP | 584 | 755 | 171 | 0.23% | $2.14K |
| LARIMAR THERAPEUTICS INC | 3,304 | 3,323 | 19 | 0.21% | -$1.09K |
| SANGAMO THERAPEUTICS INC | 19,103 | 21,371 | 2,268 | 0.21% | $21 |
| COGNITION THERAPEUTICS INC | 4,727 | 5,385 | 658 | 0.11% | -$2.59K |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 1,630,858 | 650,078 | -980,781 | 11.74% | -$981.27K |
| PRAXIS PRECISION MEDICINES INC | 1,324 | 782 | -542 | 4.43% | -$17.61K |
| BIOGEN INC | 1,104 | 1,069 | -35 | 3.47% | $21.99K |
| SCHOLAR ROCK HOLDING CORP | 4,942 | 4,306 | -636 | 3.45% | $44.55K |
| PTC THERAPEUTICS INC | 2,710 | 2,510 | -200 | 3.42% | $4.46K |
| DENALI THERAPEUTICS INC | 8,513 | 8,338 | -175 | 3.27% | $42.68K |
| CATALYST PHARMACEUTICALS INC | 7,485 | 7,110 | -375 | 3.12% | $13.57K |
| EDGEWISE THERAPEUTICS INC | 5,042 | 4,897 | -145 | 2.49% | $45.68K |
| DYNE THERAPEUTICS INC | 7,386 | 6,733 | -653 | 2.17% | -$46.32K |
| H LUNDBECK A/S | 17,826 | 17,155 | -671 | 2.08% | -$14.99K |
| AXOGEN INC | 2,961 | 2,885 | -76 | 1.81% | $34.75K |
| BIOARCTIC AB | 2,662 | 2,484 | -178 | 1.61% | $7.05K |
| NEUREN PHARMACEU | 7,165 | 6,950 | -215 | 1.45% | -$21.23K |
| TAYSHA GENE THERAPIES INC | 14,820 | 14,326 | -494 | 1.17% | -$8.90K |
| TOBII DYNAVOX AB | 6,453 | 6,211 | -242 | 1.10% | -$5.63K |
| CAPRICOR THERAPEUTICS INC | 2,677 | 2,579 | -98 | 1.02% | $39.03K |
| INTEGRA LIFESCIENCES HLDS CORP | 4,388 | 4,227 | -161 | 0.85% | -$5.61K |
| MEDINCELL SA | 1,367 | 1,318 | -49 | 0.64% | -$25.41K |
| FULCRUM THERAPEUTICS INC | 3,197 | 3,080 | -117 | 0.60% | $5.07K |
| REGENXBIO INC | 3,053 | 2,960 | -93 | 0.60% | -$5.95K |
| VANDA PHARMACEUTICALS INC | 3,668 | 3,517 | -151 | 0.48% | $10.56K |
| SOLID BIOSCIENCES INC | 3,889 | 3,717 | -172 | 0.43% | $3.05K |
| CLEARPOINT NEURO INC | 1,623 | 1,550 | -73 | 0.36% | -$17.64K |
| ENTRADA THERAPEUTICS INC | 1,495 | 1,390 | -105 | 0.29% | $5.51K |
| VOYAGER THERAPEUTICS INC | 3,021 | 2,794 | -227 | 0.20% | -$3.21K |
| ALECTOR INC | 5,082 | 4,362 | -720 | 0.15% | $774 |
| FILANA THERAPEUT | 2,799 | 2,457 | -342 | 0.09% | -$4.24K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.